Regeneron expands partnership with CytomX as other pharma partners exit

Regeneron announced it will deepen its collaboration with CytomX Therapeutics, a Bay Area biotech.

The decision follows CytomX losing several partnership agreements with other large pharmaceutical companies in recent quarters.

Regeneron’s increased commitment is expected to provide CytomX with additional resources and support for its development programs.

Industry observers view the expanded partnership as a vote of confidence in CytomX’s technology platform despite recent setbacks.